KR101249711B1 - 1-클로로-4-(β-Ｄ-글루코피라노스-1-일)-2-［4-((Ｓ)-테트라하이드로푸란-3-일옥시)-벤질］-벤젠의 결정형, 이의 제조방법 및 약제 제조를 위한 이의 용도 - Google Patents
1-클로로-4-(β-Ｄ-글루코피라노스-1-일)-2-［4-((Ｓ)-테트라하이드로푸란-3-일옥시)-벤질］-벤젠의 결정형, 이의 제조방법 및 약제 제조를 위한 이의 용도 Download PDFInfo
- Publication number
- KR101249711B1 KR101249711B1 KR1020077028240A KR20077028240A KR101249711B1 KR 101249711 B1 KR101249711 B1 KR 101249711B1 KR 1020077028240 A KR1020077028240 A KR 1020077028240A KR 20077028240 A KR20077028240 A KR 20077028240A KR 101249711 B1 KR101249711 B1 KR 101249711B1
- Authority
- KR
- South Korea
- Prior art keywords
- crystalline form
- solution
- chloro
- benzyl
- benzene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- GZZVONSODZHNOD-KWVJGPCXSA-N OC[C@H]([C@H](C([C@H]1O)=O)O)OC1c(cc1Cc(cc2)ccc2O[C@@H]2COCC2)ccc1Cl Chemical compound OC[C@H]([C@H](C([C@H]1O)=O)O)OC1c(cc1Cc(cc2)ccc2O[C@@H]2COCC2)ccc1Cl GZZVONSODZHNOD-KWVJGPCXSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05009669 | 2005-05-03 | ||
| EP05009669.2 | 2005-05-03 | ||
| EP05018012 | 2005-08-19 | ||
| EP05018012.4 | 2005-08-19 | ||
| PCT/EP2006/061956 WO2006117359A1 (en) | 2005-05-03 | 2006-05-02 | CRYSTALLINE FORM OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20080015424A KR20080015424A (ko) | 2008-02-19 |
| KR101249711B1 true KR101249711B1 (ko) | 2013-04-05 |
Family
ID=36593171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020077028240A Active KR101249711B1 (ko) | 2005-05-03 | 2006-05-02 | 1-클로로-4-(β-Ｄ-글루코피라노스-1-일)-2-［4-((Ｓ)-테트라하이드로푸란-3-일옥시)-벤질］-벤젠의 결정형, 이의 제조방법 및 약제 제조를 위한 이의 용도 |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US7713938B2 (https=) |
| EP (2) | EP2166007A1 (https=) |
| JP (2) | JP4226070B2 (https=) |
| KR (1) | KR101249711B1 (https=) |
| CN (1) | CN101155794B (https=) |
| AR (2) | AR053720A1 (https=) |
| AT (1) | ATE452883T1 (https=) |
| AU (1) | AU2006243859B8 (https=) |
| BR (1) | BRPI0610994B8 (https=) |
| CA (1) | CA2606650C (https=) |
| CY (1) | CY1109870T1 (https=) |
| DE (1) | DE602006011310D1 (https=) |
| DK (1) | DK1888552T3 (https=) |
| EA (1) | EA013079B1 (https=) |
| ES (1) | ES2337498T3 (https=) |
| HR (1) | HRP20100033T1 (https=) |
| IL (1) | IL187087A (https=) |
| ME (1) | ME01173B (https=) |
| MX (1) | MX2007013144A (https=) |
| MY (1) | MY142108A (https=) |
| NO (1) | NO339073B1 (https=) |
| NZ (1) | NZ563563A (https=) |
| PE (2) | PE20091063A1 (https=) |
| PL (1) | PL1888552T3 (https=) |
| PT (1) | PT1888552E (https=) |
| RS (1) | RS51216B (https=) |
| SI (1) | SI1888552T1 (https=) |
| TW (1) | TWI344465B (https=) |
| UA (1) | UA91546C2 (https=) |
| UY (1) | UY29505A1 (https=) |
| WO (1) | WO2006117359A1 (https=) |
| ZA (1) | ZA200705883B (https=) |
Families Citing this family (166)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| CA2678125C (en) * | 2003-11-17 | 2014-10-14 | Merck Eprova Ag | Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride |
| ATE557013T1 (de) * | 2004-03-16 | 2012-05-15 | Boehringer Ingelheim Int | Glucopyranosyl-substituierte benzol-derivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
| JP2008501657A (ja) * | 2004-06-02 | 2008-01-24 | サンド・アクチエンゲゼルシヤフト | 結晶形態のメロペネム中間体 |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| CA2587639A1 (en) * | 2004-12-16 | 2006-06-22 | Boehringer Ingelheim International Gmbh | Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| ATE445608T1 (de) * | 2005-02-23 | 2009-10-15 | Boehringer Ingelheim Int | Glucopyranosylsubstituierte ((hetero)arylethynyl- benzyl)-benzenderivative und deren verwendung als inhibitoren des natriumabhängigen glucose- cotransporters typ 2 (sglt2) |
| ATE453656T1 (de) * | 2005-04-15 | 2010-01-15 | Boehringer Ingelheim Int | Glucopyranosyl-substituierte (heteroaryloxy- benzyl)-benzen-derivate als sglt-inhibitoren |
| US7723309B2 (en) * | 2005-05-03 | 2010-05-25 | Boehringer Ingelheim International Gmbh | Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments |
| UA91546C2 (uk) | 2005-05-03 | 2010-08-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ |
| US7772191B2 (en) | 2005-05-10 | 2010-08-10 | Boehringer Ingelheim International Gmbh | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein |
| US7750153B2 (en) * | 2005-07-05 | 2010-07-06 | Hetero Drugs Limited | Process for the preparation of didanosine using novel intermediates |
| ES2346347T3 (es) * | 2005-07-27 | 2010-10-14 | Boehringer Ingelheim International Gmbh | Derivados de ((hetero)cicloalquiletinil-bencil)-benceno y su uso como inhibidores del cotransportador de glucosa dependiente de sodio (sglt). |
| CA2620566A1 (en) * | 2005-08-30 | 2007-03-08 | Boehringer Ingelheim International Gmbh | Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| TW200745075A (en) | 2005-09-08 | 2007-12-16 | Boehringer Ingelheim Int | Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments |
| AR056195A1 (es) * | 2005-09-15 | 2007-09-26 | Boehringer Ingelheim Int | Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos |
| CN101287706A (zh) * | 2005-09-21 | 2008-10-15 | 尼科梅德有限责任公司 | 作为组蛋白脱乙酰基酶抑制剂的磺酰基吡咯盐酸盐 |
| US7728129B2 (en) * | 2005-10-31 | 2010-06-01 | Janssen Pharmaceutica Nv | Processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
| WO2007093610A1 (en) * | 2006-02-15 | 2007-08-23 | Boehringer Ingelheim International Gmbh | Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture |
| PE20080697A1 (es) * | 2006-05-03 | 2008-08-05 | Boehringer Ingelheim Int | Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion |
| KR101452915B1 (ko) | 2006-05-04 | 2014-10-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 다형태 |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| AU2007260356B2 (en) * | 2006-06-16 | 2013-01-24 | H. Lundbeck A/S | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
| CA2656847A1 (en) * | 2006-08-15 | 2008-02-21 | Boehringer Ingelheim International Gmbh | Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture |
| CA2664095A1 (en) * | 2006-09-21 | 2008-03-27 | Boehringer Ingelheim International Gmbh | Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| NZ598071A (en) * | 2006-10-27 | 2013-08-30 | Signal Pharm Llc | Uses of and pharmaceutical compositions comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol compounds |
| US8283326B2 (en) * | 2006-10-27 | 2012-10-09 | Boehringer Ingelheim International Gmbh | Crystalline form of 4-(beta-D-glucopyranos-1-yl)-1-methyl-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments |
| AR063569A1 (es) | 2006-11-06 | 2009-02-04 | Boehringer Ingelheim Int | Derivados de benzil- benzonitrilo sustituidos con glucopiranosilo medicamentos que contienen a compuestos de este tipo su uso u procedimiento para su fabricacion |
| KR101100072B1 (ko) | 2006-12-21 | 2011-12-29 | 고토부키 세이야쿠 가부시키가이샤 | Ｃ-글리코시드 유도체의 제조방법 및 이의 합성 중간체 |
| JP2010519273A (ja) | 2007-02-21 | 2010-06-03 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 四置換グルコピラノシル化ベンゼン誘導体、このような化合物を含む薬物、それらの使用及びそれらの製造方法 |
| PE20090938A1 (es) | 2007-08-16 | 2009-08-08 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo |
| MX2010002027A (es) * | 2007-08-23 | 2010-03-15 | Theracos Inc | Derivados de bencilbenceno y metodos de uso. |
| JP5498392B2 (ja) * | 2007-11-30 | 2014-05-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | １，５−ジヒドロ−ピラゾロ［３，４−ｄ］ピリミジン−４−オン誘導体及びｃｎｓ障害の治療のためのｐｄｅ９ａモジュレーターとしてのそれらの使用 |
| UA101004C2 (en) | 2007-12-13 | 2013-02-25 | Теракос, Инк. | Derivatives of benzylphenylcyclohexane and use thereof |
| CL2008003653A1 (es) | 2008-01-17 | 2010-03-05 | Mitsubishi Tanabe Pharma Corp | Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica. |
| EP2085397A1 (en) * | 2008-01-21 | 2009-08-05 | Esteve Quimica, S.A. | Crystalline form of abacavir |
| ES2541141T3 (es) * | 2008-01-31 | 2015-07-16 | Astellas Pharma Inc. | Composición farmacéutica para el tratamiento de las enfermedades del hígado graso |
| US7935817B2 (en) * | 2008-03-31 | 2011-05-03 | Apotex Pharmachem Inc. | Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof |
| UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
| PE20091730A1 (es) | 2008-04-03 | 2009-12-10 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| AR071318A1 (es) * | 2008-04-15 | 2010-06-09 | Basilea Pharmaceutica Ag | Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso |
| US8097719B2 (en) * | 2008-07-15 | 2012-01-17 | Genesen Labs | Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem |
| AU2009270936B2 (en) | 2008-07-15 | 2014-12-18 | Theracos, Inc. | Deuterated benzylbenzene derivatives and methods of use |
| KR20190016601A (ko) | 2008-08-06 | 2019-02-18 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
| MX2011001855A (es) * | 2008-08-22 | 2011-03-24 | Theracos Inc | Procesos para la preparacion de inhibidores de sglt2. |
| MY155418A (en) | 2008-08-28 | 2015-10-15 | Pfizer | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
| JP5453431B2 (ja) | 2008-09-08 | 2014-03-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ピラゾロピリミジン及びｃｎｓ障害の治療のためのそれらの使用 |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| AU2016213789B2 (en) * | 2009-02-13 | 2018-01-18 | Boehringer Ingelheim International Gmbh | SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia |
| BRPI1008560B1 (pt) | 2009-02-13 | 2021-08-31 | Boehringer Ingelheim International Gmbh | Composição farmacêutica compreendendo um inibidor de sglt2, um inibidor de dpp-iv e opcionalmente um outro agente antidiabético e usos dos mesmos |
| AU2014200258B2 (en) * | 2009-02-13 | 2016-05-12 | Boehringer Ingelheim International Gmbh | SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia |
| AP2011005795A0 (en) | 2009-02-13 | 2011-08-31 | Boehringer Ingelheim Int | SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia. |
| UY32427A (es) * | 2009-02-13 | 2010-09-30 | Boheringer Ingelheim Internat Gmbh | Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma |
| KR101921934B1 (ko) * | 2009-02-13 | 2018-11-26 | 베링거 인겔하임 인터내셔날 게엠베하 | 글루코피라노실 디페닐메탄 유도체를 포함하는 약제학적 조성물, 이들의 약제학적 용량형, 이들의 제조방법 및 환자에서의 개선된 당 조절을 위한 이들의 용도 |
| PE20120505A1 (es) | 2009-03-31 | 2012-05-09 | Boehringer Ingelheim Int | Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona como moduladores de pde9a |
| AR077859A1 (es) * | 2009-08-12 | 2011-09-28 | Boehringer Ingelheim Int | Compuestos para el tratamiento de trastornos del snc |
| AU2010303123B2 (en) | 2009-09-30 | 2014-02-27 | Boehringer Ingelheim International Gmbh | Method for the preparation of a crystalline form of 1-chloro-4- (Beta-D-glucopyranos-1-yl)-2-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)benzene |
| JP5758900B2 (ja) | 2009-09-30 | 2015-08-05 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | グルコピラノシル置換ベンジルベンゼン誘導体の調製方法 |
| UY32919A (es) | 2009-10-02 | 2011-04-29 | Boehringer Ingelheim Int | Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos |
| US8163704B2 (en) | 2009-10-20 | 2012-04-24 | Novartis Ag | Glycoside derivatives and uses thereof |
| EA021983B1 (ru) | 2009-11-02 | 2015-10-30 | Пфайзер Инк. | Производные диоксабицикло[3.2.1]октан-2,3,4-триола |
| KR20240090632A (ko) | 2009-11-27 | 2024-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료 |
| PT2544679T (pt) | 2010-03-12 | 2019-07-11 | Omeros Corp | Inibidores de pde-10 e composições e métodos relacionados |
| EP2552442A1 (en) * | 2010-03-30 | 2013-02-06 | Boehringer Ingelheim International GmbH | Pharmaceutical composition comprising an sglt2 inhibitor and a ppar- gamma agonist and uses thereof |
| CA3070513C (en) | 2010-05-05 | 2023-01-03 | Boehringer Ingelheim International Gmbh | A dpp-4 inhibitor for use in treatment of skin-alterations or necrosis |
| WO2011153712A1 (en) | 2010-06-12 | 2011-12-15 | Theracos, Inc. | Crystalline form of benzylbenzene sglt2 inhibitor |
| AP2012006631A0 (en) | 2010-08-12 | 2012-12-31 | Boehringer Ingelheim Int | 6-Cycloalkyl-1, 5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A inhibitors |
| JP2013536859A (ja) * | 2010-09-01 | 2013-09-26 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５−ｈｔ２ｃアゴニストの非吸湿性塩 |
| WO2012041898A1 (en) | 2010-09-29 | 2012-04-05 | Celon Pharma Sp. Z O.O. | Combination of sglt2 inhibitor and a sugar compound for the treatment of diabetes |
| PH12013500808A1 (en) | 2010-11-02 | 2015-10-07 | Boehringer Ingelheim Int | Pharmaceutical combinations for the treatment of metabolic disorders |
| US20120283169A1 (en) * | 2010-11-08 | 2012-11-08 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| US20130035281A1 (en) | 2011-02-09 | 2013-02-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| US8809345B2 (en) | 2011-02-15 | 2014-08-19 | Boehringer Ingelheim International Gmbh | 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders |
| AR085689A1 (es) | 2011-03-07 | 2013-10-23 | Boehringer Ingelheim Int | Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2 |
| BR112013031032A2 (pt) | 2011-06-03 | 2016-11-29 | Boehringer Ingelheim Int | inibidores de sglt-2 para o tratamento de distúrbios metabólicos em pacientes tratados com agentes neurolépticos |
| US20130035298A1 (en) * | 2011-07-08 | 2013-02-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| JP2014530805A (ja) * | 2011-09-30 | 2014-11-20 | スンシネ ルアケ プハルマ カンパニー リミテッド | アジルサルタンの結晶形並びにその製造及び使用 |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| US9192617B2 (en) | 2012-03-20 | 2015-11-24 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| US9193751B2 (en) | 2012-04-10 | 2015-11-24 | Theracos, Inc. | Process for the preparation of benzylbenzene SGLT2 inhibitors |
| AU2013258109A1 (en) | 2012-05-09 | 2014-10-30 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
| WO2013171166A1 (en) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp-4 inhibitor for use in the treatment of sirs and/or sepsis |
| WO2013171167A1 (en) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
| DK2981269T3 (da) | 2013-04-04 | 2023-10-23 | Boehringer Ingelheim Vetmedica Gmbh | Behandling af stofskifteforstyrrelser hos hestedyr |
| US11813275B2 (en) | 2013-04-05 | 2023-11-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| US20160000816A1 (en) * | 2013-04-05 | 2016-01-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| CA2812016A1 (en) * | 2013-04-05 | 2014-10-05 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| US20140303097A1 (en) * | 2013-04-05 | 2014-10-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| HRP20190101T1 (hr) | 2013-04-05 | 2019-03-08 | Boehringer Ingelheim International Gmbh | Terapeutske uporabe empagliflozina |
| CA2812519A1 (en) | 2013-04-05 | 2014-10-05 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| FI4000608T3 (fi) * | 2013-04-18 | 2026-01-21 | Boehringer Ingelheim Int | Farmaseuttinen koostumus, menetelmä hoitamiseksi ja sen käyttöjä |
| WO2015051484A1 (en) | 2013-10-12 | 2015-04-16 | Theracos, Inc. | Preparation of hydroxy-benzylbenzene derivatives |
| MX376097B (es) | 2013-12-17 | 2025-03-07 | Boehringer Ingelheim Vetmedica Gmbh | Inhibidores de sglt2 para usarse en el tratamiento o prevención de trastornos metabólicos en animales felinos. |
| US9902751B2 (en) | 2013-12-30 | 2018-02-27 | Mylan Laboratories Limited | Process for the preparation of empagliflozin |
| CA2932674C (en) | 2014-01-23 | 2023-01-24 | Boehringer Ingelheim Vetmedica Gmbh | Treatment of metabolic disorders in canine animals |
| FI3721882T3 (fi) | 2014-04-01 | 2024-09-24 | Boehringer Ingelheim Vetmedica Gmbh | Aineenvaihduntahäiriöiden hoito hevoseläimissä |
| NZ716494A (en) | 2014-04-28 | 2017-07-28 | Omeros Corp | Processes and intermediates for the preparation of a pde10 inhibitor |
| NZ630803A (en) * | 2014-04-28 | 2016-03-31 | Omeros Corp | Optically active pde10 inhibitor |
| CN105384730A (zh) * | 2014-09-03 | 2016-03-09 | 杭州普晒医药科技有限公司 | 依帕列净的晶型及其制备方法、药物组合物和用途 |
| CN105481843A (zh) * | 2014-09-19 | 2016-04-13 | 重庆医药工业研究院有限责任公司 | 一种恩格列净无定型物及其制备方法 |
| EP4403230A3 (en) | 2014-09-25 | 2025-01-08 | Boehringer Ingelheim Vetmedica GmbH | Combination treatment of sglt2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals |
| EP3201191A1 (en) | 2014-10-01 | 2017-08-09 | Mylan Laboratories Ltd. | Complex of amorphous empagliflozin and a cyclodextrin |
| CZ2015110A3 (cs) | 2015-02-18 | 2016-08-31 | Zentiva, K.S. | Pevné formy empagliflozinu |
| EA201791982A1 (ru) | 2015-03-09 | 2020-02-17 | Интекрин Терапьютикс, Инк. | Способы лечения неалкогольной жировой болезни печени и/или липодистрофии |
| CZ2015279A3 (cs) | 2015-04-24 | 2016-11-02 | Zentiva, K.S. | Pevné formy amorfního empagliflozinu |
| US9879002B2 (en) | 2015-04-24 | 2018-01-30 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
| CN104788438B (zh) * | 2015-05-04 | 2018-02-02 | 南京华威医药科技集团有限公司 | 恩格列净b晶型及其制备 |
| CN106317035A (zh) * | 2015-06-23 | 2017-01-11 | 中美华世通生物医药科技（武汉）有限公司 | 恩格列净单晶及其制备方法和用途 |
| AU2016310535B2 (en) | 2015-08-27 | 2021-08-19 | Boehringer Ingelheim Vetmedica Gmbh | Liquid pharmaceutical compositions comprising SGLT-2 inhibitors |
| JP2018530592A (ja) | 2015-10-15 | 2018-10-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 代謝性ミオパチーの治療に使用するためのｓｇｌｔ−２阻害剤 |
| US9920045B2 (en) | 2015-11-04 | 2018-03-20 | Omeros Corporation | Solid state forms of a PDE10 inhibitor |
| WO2017141202A1 (en) * | 2016-02-17 | 2017-08-24 | Lupin Limited | Complex of sglt2 inhibitor and process for preparation thereof |
| AU2017233889B2 (en) * | 2016-03-16 | 2022-07-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition comprising empagliflozin and uses thereof |
| WO2017203457A1 (en) * | 2016-05-26 | 2017-11-30 | Dr. Reddy's Laboratories Limited | Solid state forms of empagliflozin |
| EP4233840A3 (en) | 2016-06-10 | 2023-10-18 | Boehringer Ingelheim International GmbH | Combinations of linagliptin and metformin |
| EP3889144A1 (en) | 2016-10-13 | 2021-10-06 | Boehringer Ingelheim International GmbH | Process for preparing glucopyranosyl-substituted benzyl-benzene derivatives |
| BR112019005930A2 (pt) | 2016-10-19 | 2019-06-11 | Boehringer Ingelheim Int | combinações compreendendo um inibidor de ssao/vap-1 e um inibidor de sglt2, e usos das mesmas |
| KR20250097990A (ko) | 2016-11-10 | 2025-06-30 | 베링거 인겔하임 인터내셔날 게엠베하 | 약제학적 조성물, 치료 방법 및 이의 용도 |
| US20200017483A1 (en) * | 2017-03-10 | 2020-01-16 | Msn Laboratories Private Limited, R&D Center | A process for the preparation of d-glucitol, 1,5-anhydro-1-c-[4-chloro-3-[[4- [[(3s)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, ( 1 s) |
| AU2018249822A1 (en) | 2017-04-03 | 2019-10-31 | Coherus Biosciences Inc. | PPArgamma agonist for treatment of progressive supranuclear palsy |
| US20210113561A1 (en) | 2018-04-17 | 2021-04-22 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| CZ2018188A3 (cs) | 2018-04-18 | 2019-10-30 | Zentiva, K.S. | Částice s obsahem amorfního empagliflozinu, způsob jejich přípravy a farmaceutický přípravek |
| KR102204439B1 (ko) | 2018-05-14 | 2021-01-18 | 에이치케이이노엔 주식회사 | Sglt-2 억제제 및 dpp-iv 억제제를 포함하는 약제학적 조성물 |
| US20210275558A1 (en) | 2018-07-25 | 2021-09-09 | Boehringer Ingelheim International Gmbh | Methods for treating, pharmaceutical compositions and uses thereof |
| WO2020039394A1 (en) | 2018-08-24 | 2020-02-27 | Novartis Ag | New drug combinations |
| EP3852730A1 (en) | 2018-09-19 | 2021-07-28 | Galenicum Health S.L.U. | Pharmaceutical compositions of empagliflozin |
| US20210393621A1 (en) | 2018-10-26 | 2021-12-23 | The Research Foundation For The State University Of New York | Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia |
| US12213970B2 (en) | 2018-10-29 | 2025-02-04 | Boehringer Ingelheim International Gmbh | Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof |
| DK3873600T5 (da) | 2018-10-29 | 2024-03-18 | Boehringer Ingelheim Int | Pyridinylsulfonamidderivater, farmaceutiske sammensætninger og anvendelser deraf |
| EP4064854A1 (en) | 2019-11-28 | 2022-10-05 | Boehringer Ingelheim Vetmedica GmbH | Use of sglt-2 inhibitors in the drying-off of non-human mammals |
| EP4076402A1 (en) | 2019-12-19 | 2022-10-26 | KRKA, d.d., Novo mesto | Dosage form comprising amorphous solid solution of empagliflozin with polymer |
| KR102111248B1 (ko) | 2019-12-30 | 2020-05-14 | 유니셀랩 주식회사 | 새로운 엠파글리플로진의 공결정 |
| JP7423800B2 (ja) | 2020-02-17 | 2024-01-29 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | ネコにおける心臓疾患の予防および／または治療のためのｓｇｌｔ－２阻害剤の使用 |
| CA3173808A1 (en) | 2020-03-06 | 2021-09-10 | Vertex Pharmaceuticals Incorporated | Methods of treating apol-1 dependent focal segmental glomerulosclerosis |
| CN111303230B (zh) * | 2020-03-09 | 2021-07-13 | 中国食品药品检定研究院 | 一种黄体酮共晶物及其制备方法和用途 |
| KR102207319B1 (ko) | 2020-03-23 | 2021-01-25 | 유니셀랩 주식회사 | 새로운 엠파글리플로진의 공결정 |
| KR102150825B1 (ko) | 2020-04-06 | 2020-09-03 | 유니셀랩 주식회사 | 새로운 sglt-2 억제제의 신규한 공결정 |
| EP4132536A1 (en) | 2020-04-07 | 2023-02-15 | Boehringer Ingelheim International GmbH | Methods for the treatment of headache disorders |
| EP4138826A1 (en) | 2020-04-22 | 2023-03-01 | Bayer Aktiengesellschaft | Combination of finerenone and a sglt2 inhibitor for the treatment and/or prevention of cardiovascular and/or renal diseases |
| WO2021250565A1 (en) * | 2020-06-10 | 2021-12-16 | Hikal Limited | An improved process for preparation of empagliflozin and its crystalline polymorph |
| WO2022051316A1 (en) | 2020-09-03 | 2022-03-10 | Coherus Biosciences, Inc. | Fixed dose combinations of chs-131 and a sglt-2 inhibitor |
| KR102218323B1 (ko) | 2020-09-09 | 2021-02-22 | 유니셀랩 주식회사 | 효율적이고 상전이가 되지 않는 엠파글리플로진 무정형의 제조방법 |
| KR20220080880A (ko) | 2020-12-08 | 2022-06-15 | 주식회사 종근당 | 엠파글리플로진 공결정을 함유하는 약제학적 조성물 |
| MX2024001184A (es) | 2021-07-28 | 2024-02-27 | Boehringer Ingelheim Vetmedica Gmbh | Uso de inhibidores de sglt-2 para la prevencion y/o tratamiento de cardiopatias en mamiferos no humanos, que excluye felinos, en particular, caninos. |
| US20240269105A1 (en) | 2021-07-28 | 2024-08-15 | Boehringer Ingelheim Vetmedica Gmbh | Use of sglt-2 inhibitors for the prevention and/or treatment of hypertension in non-human mammals |
| CN117715639A (zh) | 2021-07-28 | 2024-03-15 | 勃林格殷格翰动物保健有限公司 | Sglt-2抑制剂用于预防和/或治疗非人哺乳动物中的肾脏病的用途 |
| AU2022425078A1 (en) | 2021-12-30 | 2024-08-08 | Newamsterdam Pharma B.V. | Obicetrapib and sglt2 inhibitor combination |
| WO2023227492A1 (en) | 2022-05-25 | 2023-11-30 | Boehringer Ingelheim Vetmedica Gmbh | Aqueous pharmaceutical compositions comprising sglt-2 inhibitors |
| EP4299055A1 (en) | 2022-06-29 | 2024-01-03 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Oral dosage formulations comprising empagliflozin |
| EP4342459A1 (en) | 2022-09-20 | 2024-03-27 | Galenicum Health S.L.U. | Pharmaceutical compositions of empagliflozin |
| EP4378455A1 (en) | 2022-11-29 | 2024-06-05 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A pharmaceutical formulation comprising empagliflozin |
| EP4420658A1 (en) | 2023-02-24 | 2024-08-28 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A film coated tablet comprising empagliflozin |
| JP2026508912A (ja) | 2023-03-06 | 2026-03-13 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | 液体医薬組成物、特に１種又は複数のｓｇｌｔ－２阻害剤を含む液体医薬組成物の送達のためのシステム |
| EP4442253A1 (en) | 2023-04-04 | 2024-10-09 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A film coated tablet comprising empagliflozin and surfactant |
| EP4442252A1 (en) | 2023-04-04 | 2024-10-09 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A tablet formulation of a solid dispersion comprising empagliflozin |
| EP4442254A1 (en) | 2023-04-04 | 2024-10-09 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Film coated tablets comprising empagliflozin |
| WO2024226537A1 (en) | 2023-04-24 | 2024-10-31 | Newamsterdam Pharma B.V. | Amorphous obicetrapib and sglt2 inhibitor combination |
| CN121175053A (zh) | 2023-05-24 | 2025-12-19 | 勃林格殷格翰动物保健有限公司 | 包含一或多种sglt-2抑制剂及替米沙坦的非人类哺乳动物中肾脏疾病和/或高血压的组合治疗和/或预防 |
| TW202508593A (zh) | 2023-05-24 | 2025-03-01 | 德商百靈佳殷格翰維美迪加股份有限公司 | 包含一或多種sglt-2抑制劑及匹莫苯坦(pimobendan)及/或替米沙坦(telmisartan)之非人類哺乳動物心臟病之組合治療及/或預防 |
| KR20250007816A (ko) | 2023-07-06 | 2025-01-14 | 주식회사 경보제약 | 엠파글리플로진 ２ｌ프롤린의 신규 결정형 및 이의 제조방법 |
| KR20250038170A (ko) | 2023-09-11 | 2025-03-19 | 동광제약 주식회사 | 엠파글리플로진의 무정형 안정화 방법 |
| TW202543596A (zh) | 2024-03-15 | 2025-11-16 | 法商因文帝華公司 | 預防接受過氧化物酶體增生劑活化受體（ppar）促效劑治療患者之血液病症 |
| WO2025224069A1 (en) | 2024-04-23 | 2025-10-30 | Bayer Aktiengesellschaft | Co-crystals of finerenone, pecavaptan, and sglt2 inhibitors |
| CN119735586A (zh) * | 2025-02-25 | 2025-04-01 | 济南大学 | 一种恩格列净晶型iii及其制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1385856A2 (en) * | 2001-04-11 | 2004-02-04 | Bristol-Myers Squibb Company | Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3174901A (en) * | 1963-01-31 | 1965-03-23 | Jan Marcel Didier Aron Samuel | Process for the oral treatment of diabetes |
| NL167151C (nl) * | 1971-04-09 | 1981-11-16 | Acf Chemiefarma Nv | Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen. |
| NO154918C (no) * | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
| DE2951135A1 (de) * | 1979-12-19 | 1981-06-25 | Hoechst Ag, 6230 Frankfurt | Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
| JPS58164502A (ja) | 1982-03-26 | 1983-09-29 | Chugai Pharmaceut Co Ltd | 除草用組成物 |
| US4786755A (en) * | 1985-06-03 | 1988-11-22 | Warner-Lambert Company | Diphenic acid monoamides |
| US4602023A (en) | 1985-06-03 | 1986-07-22 | Warner-Lambert Company | Diphenic acid monoamides |
| US4786023A (en) * | 1987-08-19 | 1988-11-22 | Harris Leverett D | Drafting implement holder |
| AU6024998A (en) | 1997-01-15 | 1998-08-07 | Glycomed Incorporated | Aryl c-glycoside compounds and sulfated esters thereof |
| JPH11124392A (ja) | 1997-10-21 | 1999-05-11 | Sankyo Co Ltd | Ｃ−グリコシル化されたアリールスズ化合物 |
| US6613806B1 (en) * | 1999-01-29 | 2003-09-02 | Basf Corporation | Enhancement of the efficacy of benzoylbenzenes |
| ATE264337T1 (de) * | 1999-08-31 | 2004-04-15 | Kissei Pharmaceutical | Glucopyranosyloxypyrazol-derivate, diese enthaltende arzneimittel und zwischenprodukte zu deren herstellung |
| US6515117B2 (en) * | 1999-10-12 | 2003-02-04 | Bristol-Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
| PH12000002657B1 (en) * | 1999-10-12 | 2006-02-21 | Bristol Myers Squibb Co | C-aryl glucoside SGLT2 inhibitors |
| US6627611B2 (en) * | 2000-02-02 | 2003-09-30 | Kotobuki Pharmaceutical Co Ltd | C-glycosides and preparation of thereof as antidiabetic agents |
| JP4456768B2 (ja) | 2000-02-02 | 2010-04-28 | 壽製薬株式会社 | Ｃ−配糖体を含有する薬剤 |
| US6683056B2 (en) | 2000-03-30 | 2004-01-27 | Bristol-Myers Squibb Company | O-aryl glucoside SGLT2 inhibitors and method |
| US6872706B2 (en) | 2000-09-29 | 2005-03-29 | Kissei Pharmaceutical Co., Ltd. | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same |
| AU2002223127A1 (en) | 2000-11-30 | 2002-06-11 | Kissei Pharmaceutical Co., Ltd. Intellectual Property | Glucopyranosyloxybenzyl benzene derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| TWI255817B (en) | 2001-02-14 | 2006-06-01 | Kissei Pharmaceutical | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof |
| US6936590B2 (en) * | 2001-03-13 | 2005-08-30 | Bristol Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
| JP3698067B2 (ja) * | 2001-03-30 | 2005-09-21 | Ｊｓｒ株式会社 | 電子吸引性基および電子供与性基を有するモノマー、それを用いた共重合体、ならびにプロトン伝導膜 |
| US20030087843A1 (en) * | 2001-09-05 | 2003-05-08 | Washburn William N. | O-pyrazole glucoside SGLT2 inhibitors and method of use |
| TWI254635B (en) | 2002-08-05 | 2006-05-11 | Yamanouchi Pharma Co Ltd | Azulene derivative and salt thereof |
| US6744112B2 (en) * | 2002-10-01 | 2004-06-01 | International Business Machines Corporation | Multiple chip guard rings for integrated circuit and chip guard ring interconnect |
| DE10258007B4 (de) | 2002-12-12 | 2006-02-09 | Sanofi-Aventis Deutschland Gmbh | Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel |
| DE10258008B4 (de) | 2002-12-12 | 2006-02-02 | Sanofi-Aventis Deutschland Gmbh | Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel |
| BR0317929A (pt) | 2003-01-03 | 2006-04-11 | Bristol Myers Squibb Co | métodos de produzir inibidores de sglt2 de glicosìdeo de c-arila |
| EP1597266A4 (en) | 2003-02-27 | 2008-02-20 | Bristol Myers Squibb Co | NON-CRYOGENIC PROCESS FOR THE PRODUCTION OF GLYCOSIDES |
| ES2567571T3 (es) * | 2003-03-14 | 2016-04-25 | Astellas Pharma Inc. | Derivados de C-glucósido y sales de los mismos |
| CN1835962A (zh) * | 2003-06-03 | 2006-09-20 | 加利福尼亚大学董事会 | 利用乙酰化二糖治疗疾病的组合物与方法 |
| JP2004359630A (ja) | 2003-06-06 | 2004-12-24 | Yamanouchi Pharmaceut Co Ltd | ジフルオロジフェニルメタン誘導体及びその塩 |
| EP1679965A4 (en) | 2003-08-01 | 2009-05-27 | Janssen Pharmaceutica Nv | SUBSTITUTED ANELLIERED HETEROCYCLIC C-GLYCOSIDES |
| LT2896397T (lt) | 2003-08-01 | 2017-11-27 | Mitsubishi Tanabe Pharma Corporation | Nauji junginiai, turintys inhibitorinį aktyvumą prieš nuo natrio priklausomą gliukozės transporterį |
| US7375090B2 (en) * | 2003-08-26 | 2008-05-20 | Boehringer Ingelheim International Gmbh | Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof |
| EP1660509B1 (de) | 2003-08-26 | 2009-02-04 | Boehringer Ingelheim International GmbH | Glucopyranosyloxy-pyrazole, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
| US20050085680A1 (en) * | 2003-10-21 | 2005-04-21 | Joseph Auerbach | Method for industrial decontamination |
| US7371732B2 (en) * | 2003-12-22 | 2008-05-13 | Boehringer Ingelheim International Gmbh | Glucopyranosyloxy-substituted aromatic compounds, medicaments containing such compounds, their use and process for their manufacture |
| EP1724277A4 (en) | 2004-03-04 | 2012-05-02 | Kissei Pharmaceutical | ACCOLE HETEROCYCLIC DERIVATIVE, DRUG-CONTAINING COMPOSITION THEREOF, AND THE USE THEREOF |
| AU2005219779B2 (en) | 2004-03-04 | 2011-04-14 | Kissei Pharmaceutical Co., Ltd. | Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| ATE557013T1 (de) * | 2004-03-16 | 2012-05-15 | Boehringer Ingelheim Int | Glucopyranosyl-substituierte benzol-derivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
| US7393836B2 (en) * | 2004-07-06 | 2008-07-01 | Boehringer Ingelheim International Gmbh | D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| DE102004034690A1 (de) | 2004-07-17 | 2006-02-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Methyliden-D-xylopyranosyl-und Oxo-D-xylopyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| TW200606129A (en) | 2004-07-26 | 2006-02-16 | Chugai Pharmaceutical Co Ltd | Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same |
| EP1773800A1 (de) * | 2004-07-27 | 2007-04-18 | Boehringer Ingelheim International GmbH | D-glucopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
| WO2006018150A1 (de) | 2004-08-11 | 2006-02-23 | Boehringer Ingelheim International Gmbh | D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
| AR051446A1 (es) | 2004-09-23 | 2007-01-17 | Bristol Myers Squibb Co | Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2) |
| DE102004048388A1 (de) * | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | D-Pyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| CA2587639A1 (en) | 2004-12-16 | 2006-06-22 | Boehringer Ingelheim International Gmbh | Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| ATE445608T1 (de) | 2005-02-23 | 2009-10-15 | Boehringer Ingelheim Int | Glucopyranosylsubstituierte ((hetero)arylethynyl- benzyl)-benzenderivative und deren verwendung als inhibitoren des natriumabhängigen glucose- cotransporters typ 2 (sglt2) |
| ATE453656T1 (de) | 2005-04-15 | 2010-01-15 | Boehringer Ingelheim Int | Glucopyranosyl-substituierte (heteroaryloxy- benzyl)-benzen-derivate als sglt-inhibitoren |
| UA91546C2 (uk) | 2005-05-03 | 2010-08-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ |
| US7723309B2 (en) | 2005-05-03 | 2010-05-25 | Boehringer Ingelheim International Gmbh | Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments |
| US7772191B2 (en) * | 2005-05-10 | 2010-08-10 | Boehringer Ingelheim International Gmbh | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein |
| WO2007000445A1 (en) | 2005-06-29 | 2007-01-04 | Boehringer Ingelheim International Gmbh | Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| ES2346347T3 (es) | 2005-07-27 | 2010-10-14 | Boehringer Ingelheim International Gmbh | Derivados de ((hetero)cicloalquiletinil-bencil)-benceno y su uso como inhibidores del cotransportador de glucosa dependiente de sodio (sglt). |
| CA2620566A1 (en) | 2005-08-30 | 2007-03-08 | Boehringer Ingelheim International Gmbh | Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| TW200745075A (en) | 2005-09-08 | 2007-12-16 | Boehringer Ingelheim Int | Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments |
| AR056195A1 (es) | 2005-09-15 | 2007-09-26 | Boehringer Ingelheim Int | Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos |
| WO2007093610A1 (en) | 2006-02-15 | 2007-08-23 | Boehringer Ingelheim International Gmbh | Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture |
| PE20080697A1 (es) | 2006-05-03 | 2008-08-05 | Boehringer Ingelheim Int | Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion |
| PE20110235A1 (es) * | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| CA2656847A1 (en) * | 2006-08-15 | 2008-02-21 | Boehringer Ingelheim International Gmbh | Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture |
| CA2664095A1 (en) * | 2006-09-21 | 2008-03-27 | Boehringer Ingelheim International Gmbh | Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| US8283326B2 (en) * | 2006-10-27 | 2012-10-09 | Boehringer Ingelheim International Gmbh | Crystalline form of 4-(beta-D-glucopyranos-1-yl)-1-methyl-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments |
| AR063569A1 (es) * | 2006-11-06 | 2009-02-04 | Boehringer Ingelheim Int | Derivados de benzil- benzonitrilo sustituidos con glucopiranosilo medicamentos que contienen a compuestos de este tipo su uso u procedimiento para su fabricacion |
| AU2007316613B2 (en) * | 2006-11-09 | 2013-11-28 | Boehringer Ingelheim International Gmbh | Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions |
| CA2676620A1 (en) * | 2007-01-26 | 2008-07-31 | Boehringer Ingelheim International Gmbh | Methods for preventing and treating neurodegenerative disorders |
| JP2010519273A (ja) * | 2007-02-21 | 2010-06-03 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 四置換グルコピラノシル化ベンゼン誘導体、このような化合物を含む薬物、それらの使用及びそれらの製造方法 |
| AR065809A1 (es) * | 2007-03-22 | 2009-07-01 | Bristol Myers Squibb Co | Formulaciones farmaceuticas que contienen un inhibidor sglt2 |
| TW200904454A (en) * | 2007-03-22 | 2009-02-01 | Bristol Myers Squibb Co | Methods for treating obesity employing an SGLT2 inhibitor and compositions thereof |
| CN101754972A (zh) * | 2007-05-18 | 2010-06-23 | 百时美施贵宝公司 | Sglt2抑制剂的晶体结构及其制备方法 |
| BRPI1008560B1 (pt) * | 2009-02-13 | 2021-08-31 | Boehringer Ingelheim International Gmbh | Composição farmacêutica compreendendo um inibidor de sglt2, um inibidor de dpp-iv e opcionalmente um outro agente antidiabético e usos dos mesmos |
| UY32427A (es) * | 2009-02-13 | 2010-09-30 | Boheringer Ingelheim Internat Gmbh | Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma |
| KR101921934B1 (ko) * | 2009-02-13 | 2018-11-26 | 베링거 인겔하임 인터내셔날 게엠베하 | 글루코피라노실 디페닐메탄 유도체를 포함하는 약제학적 조성물, 이들의 약제학적 용량형, 이들의 제조방법 및 환자에서의 개선된 당 조절을 위한 이들의 용도 |
| AP2011005795A0 (en) * | 2009-02-13 | 2011-08-31 | Boehringer Ingelheim Int | SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia. |
| AU2010303123B2 (en) * | 2009-09-30 | 2014-02-27 | Boehringer Ingelheim International Gmbh | Method for the preparation of a crystalline form of 1-chloro-4- (Beta-D-glucopyranos-1-yl)-2-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)benzene |
| JP5758900B2 (ja) * | 2009-09-30 | 2015-08-05 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | グルコピラノシル置換ベンジルベンゼン誘導体の調製方法 |
| UY32919A (es) * | 2009-10-02 | 2011-04-29 | Boehringer Ingelheim Int | Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos |
-
2006
- 2006-02-05 UA UAA200713271A patent/UA91546C2/uk unknown
- 2006-04-19 US US11/406,971 patent/US7713938B2/en active Active
- 2006-04-28 UY UY29505A patent/UY29505A1/es not_active Application Discontinuation
- 2006-04-28 PE PE2009000901A patent/PE20091063A1/es active IP Right Grant
- 2006-04-28 PE PE2006000452A patent/PE20061374A1/es not_active Application Discontinuation
- 2006-05-02 WO PCT/EP2006/061956 patent/WO2006117359A1/en not_active Ceased
- 2006-05-02 RS RSP-2010/0087A patent/RS51216B/sr unknown
- 2006-05-02 DK DK06763074.9T patent/DK1888552T3/da active
- 2006-05-02 TW TW095115586A patent/TWI344465B/zh active
- 2006-05-02 DE DE602006011310T patent/DE602006011310D1/de active Active
- 2006-05-02 CN CN2006800115916A patent/CN101155794B/zh not_active Ceased
- 2006-05-02 AU AU2006243859A patent/AU2006243859B8/en active Active
- 2006-05-02 EA EA200702346A patent/EA013079B1/ru active Protection Beyond IP Right Term
- 2006-05-02 AT AT06763074T patent/ATE452883T1/de active
- 2006-05-02 SI SI200630590T patent/SI1888552T1/sl unknown
- 2006-05-02 EP EP09178479A patent/EP2166007A1/en not_active Withdrawn
- 2006-05-02 ES ES06763074T patent/ES2337498T3/es active Active
- 2006-05-02 KR KR1020077028240A patent/KR101249711B1/ko active Active
- 2006-05-02 CA CA2606650A patent/CA2606650C/en active Active
- 2006-05-02 BR BRPI0610994A patent/BRPI0610994B8/pt active IP Right Grant
- 2006-05-02 EP EP06763074A patent/EP1888552B1/en active Active
- 2006-05-02 PT PT06763074T patent/PT1888552E/pt unknown
- 2006-05-02 NZ NZ563563A patent/NZ563563A/en unknown
- 2006-05-02 PL PL06763074T patent/PL1888552T3/pl unknown
- 2006-05-02 HR HR20100033T patent/HRP20100033T1/hr unknown
- 2006-05-02 ME MEP-2010-27A patent/ME01173B/me unknown
- 2006-05-02 JP JP2008509429A patent/JP4226070B2/ja active Active
- 2006-05-02 MX MX2007013144A patent/MX2007013144A/es active IP Right Grant
- 2006-05-03 MY MYPI20062040A patent/MY142108A/en unknown
- 2006-05-03 AR ARP060101777A patent/AR053720A1/es not_active Application Discontinuation
-
2007
- 2007-07-18 ZA ZA200705883A patent/ZA200705883B/xx unknown
- 2007-07-24 NO NO20073875A patent/NO339073B1/no unknown
- 2007-11-01 IL IL187087A patent/IL187087A/en active IP Right Grant
-
2008
- 2008-10-14 JP JP2008265492A patent/JP2009046513A/ja not_active Withdrawn
-
2009
- 2009-12-22 US US12/644,560 patent/US20100099641A1/en not_active Abandoned
-
2010
- 2010-03-04 CY CY20101100207T patent/CY1109870T1/el unknown
-
2012
- 2012-07-17 AR ARP120102581A patent/AR087208A2/es not_active Application Discontinuation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1385856A2 (en) * | 2001-04-11 | 2004-02-04 | Bristol-Myers Squibb Company | Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101249711B1 (ko) | 1-클로로-4-(β-Ｄ-글루코피라노스-1-일)-2-［4-((Ｓ)-테트라하이드로푸란-3-일옥시)-벤질］-벤젠의 결정형, 이의 제조방법 및 약제 제조를 위한 이의 용도 | |
| EP1888551B1 (en) | Crystalline forms of 1-chloro-4-(beta-d-glucopyranos-1-yl)-2-[4-((r)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments | |
| EP1926720B1 (en) | CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS | |
| US8283326B2 (en) | Crystalline form of 4-(beta-D-glucopyranos-1-yl)-1-methyl-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments | |
| HK1115133B (en) | CRYSTALLINE FORM OF 1-CHLORO-4-(β-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20071203 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20100528 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20111230 Patent event code: PE09021S01D |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20120827 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20130228 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20130327 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20130328 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| A101 | Application to extend term of patent right by permit | ||
| PA0101 | Application to register extension of term of patent right by permit, etc. |
Patent event date: 20141112 Patent event code: PA01011R01D Comment text: Application to Register Extension of Term of Patent Right by Permit, etc. |
|
| J204 | Request for invalidation trial [patent] | ||
| PJ0204 | Invalidation trial for patent |
Appeal kind category: Invalidation Request date: 20150327 Decision date: 20160621 Appeal identifier: 2015100001551 Patent event date: 20150327 Comment text: Request for Trial Patent event code: PJ02042R01D Patent event date: 20130327 Comment text: Registration of Establishment Patent event code: PJ02041E01I Appeal kind category: Invalidation Request date: 20150327 Decision date: 20170615 Appeal identifier: 2015100001502 |
|
| J204 | Request for invalidation trial [patent] | ||
| PJ0204 | Invalidation trial for patent |
Patent event date: 20150328 Comment text: Request for Trial Patent event code: PJ02042R01D Patent event date: 20130327 Comment text: Registration of Establishment Patent event code: PJ02041E01I Appeal kind category: Invalidation Request date: 20150328 Decision date: 20171201 Appeal identifier: 2015100001646 |
|
| J204 | Request for invalidation trial [patent] | ||
| PJ0204 | Invalidation trial for patent |
Patent event date: 20150330 Comment text: Request for Trial Patent event code: PJ02042R01D Patent event date: 20130327 Comment text: Registration of Establishment Patent event code: PJ02041E01I Appeal kind category: Invalidation Request date: 20150330 Decision date: 20171201 Appeal identifier: 2015100001705 |
|
| J204 | Request for invalidation trial [patent] | ||
| PJ0204 | Invalidation trial for patent |
Appeal kind category: Invalidation Request date: 20150403 Decision date: 20151216 Appeal identifier: 2015100002066 Appeal kind category: Invalidation Request date: 20150403 Decision date: 20171122 Appeal identifier: 2015100001925 Appeal kind category: Invalidation Request date: 20150403 Decision date: 20151014 Appeal identifier: 2015100001920 Patent event date: 20150403 Comment text: Request for Trial Patent event code: PJ02042R01D Patent event date: 20130327 Comment text: Registration of Establishment Patent event code: PJ02041E01I Appeal kind category: Invalidation Request date: 20150403 Decision date: 20171122 Appeal identifier: 2015100001882 |
|
| J204 | Request for invalidation trial [patent] | ||
| PJ0204 | Invalidation trial for patent |
Patent event date: 20150409 Comment text: Request for Trial Patent event code: PJ02042R01D Patent event date: 20130327 Comment text: Registration of Establishment Patent event code: PJ02041E01I Appeal kind category: Invalidation Request date: 20150409 Decision date: 20171122 Appeal identifier: 2015100002279 |
|
| J204 | Request for invalidation trial [patent] | ||
| PJ0204 | Invalidation trial for patent |
Appeal kind category: Invalidation Request date: 20150410 Decision date: 20150706 Appeal identifier: 2015100002593 Appeal kind category: Invalidation Request date: 20150410 Decision date: 20171201 Appeal identifier: 2015100002456 Patent event date: 20150410 Comment text: Request for Trial Patent event code: PJ02042R01D Patent event date: 20130327 Comment text: Registration of Establishment Patent event code: PJ02041E01I Appeal kind category: Invalidation Request date: 20150410 Decision date: 20150617 Appeal identifier: 2015100002453 |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20150617 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2015100002453 Request date: 20150410 Appeal kind category: Invalidation Decision date: 20150617 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20150701 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20180518 Request date: 20150701 Appeal identifier: 2015100003747 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20150706 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2015100002593 Request date: 20150410 Appeal kind category: Invalidation Decision date: 20150706 |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20151014 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2015100001920 Request date: 20150403 Appeal kind category: Invalidation Decision date: 20151014 |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20151216 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2015100002066 Request date: 20150403 Appeal kind category: Invalidation Decision date: 20151216 |
|
| FPAY | Annual fee payment |
Payment date: 20160322 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20160322 Start annual number: 4 End annual number: 4 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20160613 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20180518 Request date: 20160613 Appeal identifier: 2016100001576 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20160621 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2015100001551 Request date: 20150327 Appeal kind category: Invalidation Decision date: 20160621 |
|
| FPAY | Annual fee payment |
Payment date: 20170317 Year of fee payment: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20170317 Start annual number: 5 End annual number: 5 |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20170615 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2015100001502 Request date: 20150327 Appeal kind category: Invalidation Decision date: 20170615 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2015100001882; TRIAL DECISION FOR INVALIDATION REQUESTED 20150403 Effective date: 20171122 Free format text: TRIAL NUMBER: 2015100001925; TRIAL DECISION FOR INVALIDATION REQUESTED 20150403 Effective date: 20171122 Free format text: TRIAL NUMBER: 2015100002279; TRIAL DECISION FOR INVALIDATION REQUESTED 20150409 Effective date: 20171122 |
|
| PJ1301 | Trial decision |
Appeal kind category: Invalidation Request date: 20150409 Decision date: 20171122 Appeal identifier: 2015100002279 Appeal kind category: Invalidation Request date: 20150403 Decision date: 20171122 Appeal identifier: 2015100001925 Patent event code: PJ13011S08D Patent event date: 20171122 Comment text: Consolidated Trial Decision Appeal kind category: Invalidation Request date: 20150403 Decision date: 20171122 Appeal identifier: 2015100001882 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2015100001705; TRIAL DECISION FOR INVALIDATION REQUESTED 20150330 Effective date: 20171201 |
|
| PJ1301 | Trial decision |
Patent event code: PJ13011S05D Patent event date: 20171201 Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design) Appeal kind category: Invalidation Request date: 20150330 Decision date: 20171201 Appeal identifier: 2015100001705 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2015100001646; TRIAL DECISION FOR INVALIDATION REQUESTED 20150328 Effective date: 20171201 |
|
| PJ1301 | Trial decision |
Appeal kind category: Invalidation Request date: 20150410 Decision date: 20171201 Appeal identifier: 2015100002456 Patent event code: PJ13011S05D Patent event date: 20171204 Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design) Appeal kind category: Invalidation Request date: 20150328 Decision date: 20171201 Appeal identifier: 2015100001646 |
|
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20190523 Request date: 20180115 Appeal identifier: 2018100000142 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20180115 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20190523 Request date: 20180115 Appeal identifier: 2018100000141 Appeal kind category: Confirmation of the scope of right_defensive |
|
| PG1701 | Publication of correction |
Publication date: 20180322 |
|
| FPAY | Annual fee payment |
Payment date: 20180316 Year of fee payment: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20180316 Start annual number: 6 End annual number: 6 |
|
| PG1701 | Publication of correction |
Publication date: 20180322 |
|
| PG1701 | Publication of correction |
Publication date: 20180322 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2015100003747; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20150701 Effective date: 20180518 |
|
| PJ1301 | Trial decision |
Appeal kind category: Confirmation of the scope of right_defensive Request date: 20160613 Decision date: 20180518 Appeal identifier: 2016100001576 Patent event code: PJ13011S02D Patent event date: 20180518 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20150701 Decision date: 20180518 Appeal identifier: 2015100003747 |
|
| PJ2001 | Appeal |
Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200429 Appeal identifier: 2018200005655 Request date: 20180710 Patent event date: 20180518 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Patent event code: PJ20011S02I Patent event date: 20171204 Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design) Patent event code: PJ20011S05I Patent event date: 20171201 Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design) Patent event code: PJ20011S05I Patent event date: 20171122 Comment text: Consolidated Trial Decision Patent event code: PJ20011S08I Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200429 Appeal identifier: 2018200005648 Request date: 20180710 |
|
| PR1001 | Payment of annual fee |
Payment date: 20190315 Start annual number: 7 End annual number: 7 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2018100000141; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180115 Effective date: 20190523 Free format text: TRIAL NUMBER: 2018100000142; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20180115 Effective date: 20190523 |
|
| PJ1301 | Trial decision |
Appeal kind category: Confirmation of the scope of right_defensive Request date: 20180115 Decision date: 20190523 Appeal identifier: 2018100000142 Patent event code: PJ13011S02D Patent event date: 20190523 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20180115 Decision date: 20190523 Appeal identifier: 2018100000141 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20190625 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20191230 Request date: 20190625 Appeal identifier: 2019100002064 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20190729 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200102 Request date: 20190729 Appeal identifier: 2019100002433 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20190809 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20191230 Request date: 20190809 Appeal identifier: 2019100002575 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20190827 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200320 Request date: 20190827 Appeal identifier: 2019100002745 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20191230 Request date: 20190909 Appeal identifier: 2019100002905 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20190909 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20191230 Request date: 20190909 Appeal identifier: 2019100002904 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200320 Request date: 20190920 Appeal identifier: 2019100002989 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200320 Request date: 20190920 Appeal identifier: 2019100002988 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20190920 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200320 Request date: 20190920 Appeal identifier: 2019100002983 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200320 Request date: 20190927 Appeal identifier: 2019100003053 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20190927 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200320 Request date: 20190927 Appeal identifier: 2019100003052 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200320 Request date: 20191011 Appeal identifier: 2019100003185 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20191011 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200320 Request date: 20191011 Appeal identifier: 2019100003184 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20191205 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200320 Request date: 20191205 Appeal identifier: 2019100003883 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20191211 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200323 Request date: 20191211 Appeal identifier: 2019100003957 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Appeal identifier: 2019100002905 Request date: 20190909 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20191230 Appeal identifier: 2019100002904 Request date: 20190909 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20191230 Appeal identifier: 2019100002575 Request date: 20190809 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20191230 Patent event code: PJ12011R01D Patent event date: 20191230 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2019100002064 Request date: 20190625 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20191230 |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20200102 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2019100002433 Request date: 20190729 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200102 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200110 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200323 Request date: 20200110 Appeal identifier: 2020100000087 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200214 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200323 Request date: 20200214 Appeal identifier: 2020100000499 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200601 Request date: 20200309 Appeal identifier: 2020100000762 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20200309 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200309 Appeal identifier: 2020100000761 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200310 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200310 Appeal identifier: 2020100000767 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200311 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200311 Appeal identifier: 2020100000799 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200601 Request date: 20200318 Appeal identifier: 2020100000882 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200601 Request date: 20200318 Appeal identifier: 2020100000881 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20200318 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200318 Appeal identifier: 2020100000880 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200601 Request date: 20200319 Appeal identifier: 2020100000899 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200601 Request date: 20200319 Appeal identifier: 2020100000898 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20200319 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200319 Appeal identifier: 2020100000897 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2019100002745; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190827 Effective date: 20200320 Free format text: TRIAL NUMBER: 2019100002989; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190920 Effective date: 20200320 Free format text: TRIAL NUMBER: 2019100003052; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190927 Effective date: 20200320 Free format text: TRIAL NUMBER: 2019100002983; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190920 Effective date: 20200320 Free format text: TRIAL NUMBER: 2019100003184; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20191011 Effective date: 20200320 Free format text: TRIAL NUMBER: 2019100003053; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190927 Effective date: 20200320 Free format text: TRIAL NUMBER: 2019100002988; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20190920 Effective date: 20200320 Free format text: TRIAL NUMBER: 2019100003185; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20191011 Effective date: 20200320 Free format text: TRIAL NUMBER: 2019100003883; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20191205 Effective date: 20200320 |
|
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200515 Request date: 20200320 Appeal identifier: 2020100000919 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200601 Request date: 20200320 Appeal identifier: 2020100000918 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20200320 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200320 Appeal identifier: 2020100000917 Appeal kind category: Confirmation of the scope of right_defensive |
|
| PJ1301 | Trial decision |
Appeal kind category: Confirmation of the scope of right_defensive Request date: 20191205 Decision date: 20200320 Appeal identifier: 2019100003883 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20191011 Decision date: 20200320 Appeal identifier: 2019100003185 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20191011 Decision date: 20200320 Appeal identifier: 2019100003184 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20190927 Decision date: 20200320 Appeal identifier: 2019100003053 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20190927 Decision date: 20200320 Appeal identifier: 2019100003052 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20190920 Decision date: 20200320 Appeal identifier: 2019100002989 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20190920 Decision date: 20200320 Appeal identifier: 2019100002988 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20190920 Decision date: 20200320 Appeal identifier: 2019100002983 Patent event code: PJ13011S02D Patent event date: 20200320 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20190827 Decision date: 20200320 Appeal identifier: 2019100002745 |
|
| PR1001 | Payment of annual fee |
Payment date: 20200320 Start annual number: 8 End annual number: 8 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2020100000087; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200110 Effective date: 20200323 Free format text: TRIAL NUMBER: 2019100003957; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20191211 Effective date: 20200323 Free format text: TRIAL NUMBER: 2020100000499; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200214 Effective date: 20200323 |
|
| PJ1301 | Trial decision |
Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200214 Decision date: 20200323 Appeal identifier: 2020100000499 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200110 Decision date: 20200323 Appeal identifier: 2020100000087 Patent event code: PJ13011S02D Patent event date: 20200323 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20191211 Decision date: 20200323 Appeal identifier: 2019100003957 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200324 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200324 Appeal identifier: 2020100000941 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200601 Request date: 20200325 Appeal identifier: 2020100000970 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20200325 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200325 Appeal identifier: 2020100000969 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200601 Request date: 20200326 Appeal identifier: 2020100000995 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200601 Request date: 20200326 Appeal identifier: 2020100000994 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200601 Request date: 20200326 Appeal identifier: 2020100000993 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20200326 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200326 Appeal identifier: 2020100000985 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200601 Request date: 20200327 Appeal identifier: 2020100001008 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200327 Request date: 20200327 Appeal identifier: 2020100000999 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200327 Request date: 20200327 Appeal identifier: 2020100000998 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200601 Request date: 20200327 Appeal identifier: 2020100000997 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20200327 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200327 Appeal identifier: 2020100000996 Appeal kind category: Confirmation of the scope of right_defensive |
|
| PJ1201 | Withdrawal of trial |
Appeal identifier: 2020100000999 Request date: 20200327 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200327 Patent event code: PJ12011R01D Patent event date: 20200327 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2020100000998 Request date: 20200327 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200327 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200330 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200330 Appeal identifier: 2020100001031 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200403 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200403 Appeal identifier: 2020100001090 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200406 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200406 Appeal identifier: 2020100001103 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200407 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200407 Appeal identifier: 2020100001110 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200601 Request date: 20200408 Appeal identifier: 2020100001131 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20200408 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200408 Appeal identifier: 2020100001130 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200414 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200414 Appeal identifier: 2020100001207 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200601 Request date: 20200416 Appeal identifier: 2020100001220 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20200416 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200416 Appeal identifier: 2020100001217 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20200601 Request date: 20200417 Appeal identifier: 2020100001243 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20200417 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200417 Appeal identifier: 2020100001232 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200420 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20200601 Request date: 20200420 Appeal identifier: 2020100001264 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Decision date: 20210105 Request date: 20200429 Appeal identifier: 2020100001378 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20210105 Request date: 20200429 Appeal identifier: 2020100001377 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20200429 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20210105 Request date: 20200429 Appeal identifier: 2020100001376 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200430 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20210105 Request date: 20200430 Appeal identifier: 2020100001379 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J122 | Written withdrawal of action (patent court) | ||
| PJ1202 | Withdrawal of action (patent court) |
Decision date: 20200429 Request date: 20180710 Appeal identifier: 2018200005655 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ12021R01D Patent event date: 20200508 Comment text: Written Withdrawal of Action Decision date: 20200429 Request date: 20180710 Appeal identifier: 2018200005648 Appeal kind category: Confirmation of the scope of right_defensive |
|
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20200515 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2020100000919 Request date: 20200320 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20200515 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2020100001008; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200327 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000995; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200326 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000997; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200327 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100001220; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200416 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100001131; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200408 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000799; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200311 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000881; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200318 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100001031; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200330 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000897; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200319 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000941; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200324 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000898; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200319 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100001207; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200414 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000969; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200325 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000899; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200319 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000985; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200326 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100001130; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200408 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100001103; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200406 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000767; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200310 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000880; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200318 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000996; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200327 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100001232; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200417 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100001110; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200407 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100001243; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200417 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100001217; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200416 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000917; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200320 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000882; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200318 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000918; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200320 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000761; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200309 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000993; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200326 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000762; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200309 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000994; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200326 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100001090; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200403 Effective date: 20200601 Free format text: TRIAL NUMBER: 2020100000970; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200325 Effective date: 20200601 |
|
| PJ1301 | Trial decision |
Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200420 Decision date: 20200601 Appeal identifier: 2020100001264 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200417 Decision date: 20200601 Appeal identifier: 2020100001243 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200417 Decision date: 20200601 Appeal identifier: 2020100001232 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200416 Decision date: 20200601 Appeal identifier: 2020100001220 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200416 Decision date: 20200601 Appeal identifier: 2020100001217 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200414 Decision date: 20200601 Appeal identifier: 2020100001207 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200408 Decision date: 20200601 Appeal identifier: 2020100001131 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200408 Decision date: 20200601 Appeal identifier: 2020100001130 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200407 Decision date: 20200601 Appeal identifier: 2020100001110 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200406 Decision date: 20200601 Appeal identifier: 2020100001103 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200403 Decision date: 20200601 Appeal identifier: 2020100001090 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200330 Decision date: 20200601 Appeal identifier: 2020100001031 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200327 Decision date: 20200601 Appeal identifier: 2020100001008 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200327 Decision date: 20200601 Appeal identifier: 2020100000997 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200327 Decision date: 20200601 Appeal identifier: 2020100000996 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200326 Decision date: 20200601 Appeal identifier: 2020100000995 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200326 Decision date: 20200601 Appeal identifier: 2020100000994 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200326 Decision date: 20200601 Appeal identifier: 2020100000993 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200326 Decision date: 20200601 Appeal identifier: 2020100000985 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200325 Decision date: 20200601 Appeal identifier: 2020100000970 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200325 Decision date: 20200601 Appeal identifier: 2020100000969 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200324 Decision date: 20200601 Appeal identifier: 2020100000941 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200320 Decision date: 20200601 Appeal identifier: 2020100000918 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200320 Decision date: 20200601 Appeal identifier: 2020100000917 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200319 Decision date: 20200601 Appeal identifier: 2020100000899 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200319 Decision date: 20200601 Appeal identifier: 2020100000898 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200319 Decision date: 20200601 Appeal identifier: 2020100000897 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200318 Decision date: 20200601 Appeal identifier: 2020100000882 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200318 Decision date: 20200601 Appeal identifier: 2020100000881 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200318 Decision date: 20200601 Appeal identifier: 2020100000880 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200311 Decision date: 20200601 Appeal identifier: 2020100000799 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200310 Decision date: 20200601 Appeal identifier: 2020100000767 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200309 Decision date: 20200601 Appeal identifier: 2020100000762 Patent event code: PJ13011S02D Patent event date: 20200601 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200309 Decision date: 20200601 Appeal identifier: 2020100000761 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200805 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20210106 Request date: 20200805 Appeal identifier: 2020100002350 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200806 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20210106 Request date: 20200806 Appeal identifier: 2020100002373 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200810 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20210106 Request date: 20200810 Appeal identifier: 2020100002433 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200811 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20210416 Request date: 20200811 Appeal identifier: 2020100002453 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20200824 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20210106 Request date: 20200824 Appeal identifier: 2020100002550 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2020100001377; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200429 Effective date: 20210105 Free format text: TRIAL NUMBER: 2020100001379; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200430 Effective date: 20210105 Free format text: TRIAL NUMBER: 2020100001378; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200429 Effective date: 20210105 Free format text: TRIAL NUMBER: 2020100001376; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200429 Effective date: 20210105 |
|
| PJ1301 | Trial decision |
Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200430 Decision date: 20210105 Appeal identifier: 2020100001379 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200429 Decision date: 20210105 Appeal identifier: 2020100001378 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200429 Decision date: 20210105 Appeal identifier: 2020100001377 Patent event code: PJ13011S02D Patent event date: 20210105 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200429 Decision date: 20210105 Appeal identifier: 2020100001376 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2020100002433; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200810 Effective date: 20210106 Free format text: TRIAL NUMBER: 2020100002350; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200805 Effective date: 20210106 Free format text: TRIAL NUMBER: 2020100002373; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20200806 Effective date: 20210106 |
|
| PJ1301 | Trial decision |
Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200824 Decision date: 20210106 Appeal identifier: 2020100002550 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200810 Decision date: 20210106 Appeal identifier: 2020100002433 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200806 Decision date: 20210106 Appeal identifier: 2020100002373 Patent event code: PJ13011S02D Patent event date: 20210106 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200805 Decision date: 20210106 Appeal identifier: 2020100002350 |
|
| PR1001 | Payment of annual fee |
Payment date: 20210319 Start annual number: 9 End annual number: 9 |
|
| PJ1301 | Trial decision |
Patent event code: PJ13011S02D Patent event date: 20210416 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20200811 Decision date: 20210416 Appeal identifier: 2020100002453 |
|
| PR1001 | Payment of annual fee |
Payment date: 20220318 Start annual number: 10 End annual number: 10 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20220623 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20221108 Request date: 20220623 Appeal identifier: 2022100001781 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20220720 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Decision date: 20221108 Request date: 20220720 Appeal identifier: 2022100002043 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2022100002043; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20220720 Effective date: 20221108 Free format text: TRIAL NUMBER: 2022100001781; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20220623 Effective date: 20221108 |
|
| PJ1301 | Trial decision |
Appeal kind category: Confirmation of the scope of right_defensive Request date: 20220720 Decision date: 20221108 Appeal identifier: 2022100002043 Patent event code: PJ13011S02D Patent event date: 20221108 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20220623 Decision date: 20221108 Appeal identifier: 2022100001781 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20221221 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Request date: 20221221 Appeal identifier: 2022100003537 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2022100003537; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20221221 Effective date: 20230727 |
|
| PJ1301 | Trial decision |
Patent event code: PJ13011S02D Patent event date: 20230727 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20221221 Decision date: 20230727 Appeal identifier: 2022100003537 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Request date: 20230818 Appeal identifier: 2023100002766 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20230818 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Request date: 20230818 Appeal identifier: 2023100002765 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2023100002765; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20230818 Effective date: 20231030 |
|
| PJ1301 | Trial decision |
Appeal kind category: Confirmation of the scope of right_defensive Request date: 20230818 Decision date: 20231030 Appeal identifier: 2023100002766 Patent event code: PJ13011S02D Patent event date: 20231030 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20230818 Decision date: 20231030 Appeal identifier: 2023100002765 |
|
| PR1001 | Payment of annual fee |
Payment date: 20240315 Start annual number: 12 End annual number: 12 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Request date: 20240329 Appeal identifier: 2024100000947 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20240329 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Request date: 20240329 Appeal identifier: 2024100000932 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20240530 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2024100000932 Request date: 20240329 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Request date: 20240610 Appeal identifier: 2024100001688 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20240610 Appeal identifier: 2024100001687 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20240610 Appeal identifier: 2024100001686 Appeal kind category: Confirmation of the scope of right_defensive Patent event code: PJ02062R01D Patent event date: 20240610 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Request date: 20240610 Appeal identifier: 2024100001685 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20240719 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Request date: 20240719 Appeal identifier: 2024100002157 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2024100001688; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20240610 Effective date: 20240823 Free format text: TRIAL NUMBER: 2024100001687; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20240610 Effective date: 20240823 Free format text: TRIAL NUMBER: 2024100001686; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20240610 Effective date: 20240823 Free format text: TRIAL NUMBER: 2024100001685; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20240610 Effective date: 20240823 |
|
| PJ1301 | Trial decision |
Appeal kind category: Confirmation of the scope of right_defensive Request date: 20240610 Decision date: 20240823 Appeal identifier: 2024100001688 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20240610 Decision date: 20240823 Appeal identifier: 2024100001687 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20240610 Decision date: 20240823 Appeal identifier: 2024100001686 Patent event code: PJ13011S02D Patent event date: 20240823 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20240610 Decision date: 20240823 Appeal identifier: 2024100001685 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2024100002157; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20240719 Effective date: 20240924 Free format text: TRIAL NUMBER: 2024100000947; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20240329 Effective date: 20240924 |
|
| PJ1301 | Trial decision |
Appeal kind category: Confirmation of the scope of right_defensive Request date: 20240719 Decision date: 20240924 Appeal identifier: 2024100002157 Patent event code: PJ13011S02D Patent event date: 20240924 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20240329 Decision date: 20240924 Appeal identifier: 2024100000947 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20241018 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Request date: 20241018 Appeal identifier: 2024100003027 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20241105 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Request date: 20241105 Appeal identifier: 2024100003196 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20241224 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Request date: 20241224 Appeal identifier: 2024100003707 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20241230 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20130327 Comment text: Registration of Establishment Request date: 20241230 Appeal identifier: 2024100003750 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2024100003196; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20241105 Effective date: 20250227 Free format text: TRIAL NUMBER: 2024100003027; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20241018 Effective date: 20250227 |
|
| PJ1301 | Trial decision |
Appeal kind category: Confirmation of the scope of right_defensive Request date: 20241105 Decision date: 20250227 Appeal identifier: 2024100003196 Patent event code: PJ13011S02D Patent event date: 20250227 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20241018 Decision date: 20250227 Appeal identifier: 2024100003027 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20241224 Decision date: 20250227 Appeal identifier: 2024100003707 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2024100003750; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20241230 Effective date: 20250610 |
|
| PJ1301 | Trial decision |
Patent event code: PJ13011S02D Patent event date: 20250610 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20241230 Decision date: 20250610 Appeal identifier: 2024100003750 |